NOV
45
2
CFG
36
12
DE
49
3
NDAQ
46
2
ES
12
3
XRX
48
2
DLTR
52
8
AMP
43
2
SLG
37
6
ADBE
50
3
FSLR
50
6
AIZ
61
5
RRC
52
2
HPQ
55
3
AN
49
2
CI
35
2
PEG
53
7
CTSH
55
3
EMR
57
7
DRI
72
3
NOV
45
2
CFG
36
12
DE
49
3
NDAQ
46
2
ES
12
3
XRX
48
2
DLTR
52
8
AMP
43
2
SLG
37
6
ADBE
50
3
FSLR
50
6
AIZ
61
5
RRC
52
2
HPQ
55
3
AN
49
2
CI
35
2
PEG
53
7
CTSH
55
3
EMR
57
7
DRI
72
3
Financhill
Back

AbbVie 10K Form

Sell
40

ABBV
AbbVie

Last Price:
$175.68
Seasonality Move:
1.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-03 10Q ABBV/AbbVie Quarterly
2023-11-06 10Q ABBV/AbbVie Quarterly
2023-08-07 10Q ABBV/AbbVie Quarterly
2023-05-05 10Q ABBV/AbbVie Quarterly
2022-11-04 10Q ABBV/AbbVie Quarterly
2022-08-04 10Q ABBV/AbbVie Quarterly

Receive ABBV News And Ratings

See the #1 stock for the next 7 days that we like better than ABBV

ABBV Financial Statistics

Sales & Book Value

Annual Sales: $54.3B
Cash Flow: $5.2B
Price / Cash Flow: 19.93
Annual Sales: $3.41
Price / Book: 51.44

Profitability

EPS (TTM): 2.88000
Net Income (TTM): $5.1B
Gross Margin: $33.9B
Return on Equity: 58.92%
Return on Assets: 3.63%

AbbVie Earnings Forecast

Key AbbVie Financial Ratios

  • The Gross Profit Margin over the past 15 years for ABBV is 62.42%.
  • The Selling, General & Administrative Expenses for ABBV have been equal to 23.70% of Gross Profit Margin.
  • The Research & Development expenses have been 15.56% of Revenue.
  • The Interest Expense is 45.73% of Operating Income.
  • The Net Earning history of ABBV is 8.95% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

AbbVie Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: ABBV
CUSIP: 00287Y
Website: abbvieinvestor.com

Debt

Debt-to-Equity Ratio: 11.78
Current Ratio: 0.65
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 64.55
Forward P/E Ratio: 14.42

ABBV Technical Analysis vs Fundamental Analysis

Sell
40
AbbVie (ABBV) is a Sell

Is AbbVie a Buy or a Sell?

  • AbbVie stock is rated a Sell
    The current AbbVie [ABBV] share price is $175.58. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.